Page 12 - 80_03

NOTICIAS
CIENTÍFICAS…

Aradhye,
S.;
Burtin,
P.
“Fingolimod
(FTY720):
discovery
and
development
of
an
oral
drug

to
treat
multiple
sclerosis”
Nat.
Rev.
Drug
Discov.
2010,
9,
883-­-897.
b)
Vasiliou,
S.
“Oral

Fingolimod
for
the
treatment
of
relapsing-­-remitting
multiple
sclerosis”
Drugs
Today
2010,

46,
315-­-325.

14.
Compston
A,
Coles
A.
Multiple
sclerosis.
Lancet.
2002,
359,1221-­-1231.

15.
a)
Putzki,
N.;
Baranwal,
M.
K.;
Tettenborn,
B.;
Limmroth,
V.;
Kreuzfelder,
E.
“Effects
of

natalizumab
on
circulating
B
cells:
T
regulatory
cells
and
natural
killer
cells”,
Eur.
Neurol.

2010;
63,
311-­-317.
b)
Buttmann,
M.
“Treating
multiple
sclerosis
with
monoclonal

antibodies:
a
2010
update”
Expert
Rev.
Neurother.
2010,
10,
791-­-809.
c)
Niino,
M.;
Sasaki,

H.
“Update
on
the
treatment
options
for
multiple
sclerosis”
Expert
Rev.
Clin.
Immunol.

2010,
6,
77-­-88.

16.
Comi,
G.;
Jeffery,
D.;
Kappos,
L.;
Montalban,
X.;
Boyko,
A.;
Rocca,
M.
A.;
Filippi,
M.;
Allegro

Study,
G.
"Placebo-­-Controlled
Trial
of
Oral
Laquinimod
for
Multiple
Sclerosis"
New
Engl,
J.

Med.
2012,
366,
1000-­-1009.

17.
a)
Igarashi,
N.
et
al.
Sphingosine
kinase
2
is
a
nuclear
protein
and
inhibits
DNA
synthesis.
J.

Biol.
Chem.
2003,
278,
46832-­-46839.
b)
Hait,
N.C.
et
al.
“Regulation
of
histone
acetylation

in
the
nucleus
by
sphingosine-­-
1-­-phosphate”
Science
2009,
325,
1254-­-1257.

18.
Carey,
N.;
La
Thangue,
N.
B.
Curr.
Opin.
Pharmacol.
2006,
6,
369.

19.
Fischer,
A.;
Sananbenesi,
F.;
Mungenast,
A.;
Tsai,
L.
H.
“Targeting
the
correct
HDAC(s)
to

treat
cognitive
disorders”
Trends
Pharmacol.
Sci.
2010,
31,
605-­-617.

20.
Brynskikh,
A.:
Warren,
T.;
Zhu,
J.;
Kipnis,
J.
“Adaptive
immunity
affects
learning
behavior
in

mice”
Brain
Behav.
Immun.
2008,
22,
861-­-869.

21.
Brynskikh,
A.,
Warren,
T.,
Zhu,
J.,
Kipnis,
J.
“Adaptive
immunity
affects
learning
behavior
in

mice”
Brain
Behav.
Immun.
2008,
22,
861-­-869.

22.
Matheos,
D.
P.;
Word,
M.
A.
“Unlocking
the
constraints
on
memory
formation”,
Nature

Neurosc.
2014,
17,
895-­-896.

23.
Flores,
A.;
Valls-­-Comamala,
V.;
Costa,
G.;
Saravia,
R.;
Maldonado,
R.;
Berrendero,
F.
“The

Hypocretin/Orexin
System
Mediates
the
Extinction
of
Fear
Memories”

Neuropsychopharmacology
2014
doi:
10.1038/npp.2014.146.

465